OVN 0.00% 2.0¢ oventus medical limited

Ann: Director Appointment, page-3

  1. 145 Posts.
    lightbulb Created with Sketch. 40
    Oh hey @Davisite, you are here too.

    Hahah... breathing? the chart looks like this patient has passed.. hahahah

    In comparison SOM is doing pretty well, they are the market leader in MAD. Solid growth (+20% YoY) in US and EU and moving towards a smart-MAD (RestAssure).. I think it will be the next ResMed
 
watchlist Created with Sketch. Add OVN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.